The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.
Targeting Protein–Protein Interactions for Therapeutic Intervention: A Challenge for the Future
Abstract
BACKGROUND: Over the last two decades, an increasing research effort in academia and industry has focused on the modulation (both inhibition and stabilization) of protein-protein interactions (PPIs) in order to develop novel therapeutic approaches and target-selective agents in drug discovery. DISCUSSION: The diversity and complexity of highly dynamic systems such as PPIs present many challenges for the identification of drug-like molecules with the ability to modulate the PPI with the necessary selectivity and potency. In this review, a number of these strategies will be presented along with a critical overview of the challenges and potential solutions relating to the exploitation of PPIs as molecular targets. CONCLUSIONS: Both traditional drug discovery approaches and some more recently developed innovative strategies have already provided valuable tools for the discovery of PPI modulators, and a number of successful examples have highlighted the potential of targeting PPIs for therapeutic intervention, especially in the oncology area.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–210 of 210
HIV-1 assembly and budding as targets for drug discovery.
Li, F., & Wild, C. T. (2005) · PubMed · Cited by 19
Lerner, M. G., Meagher, K. L., & Carlson, H. A. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-008-9231-6 · Cited by 15
Discovery of Inhibitors of Protein-Protein Interactions from Combinatorial Libraries
Vicent, M. J., Pérez‐Payá, E., & Orzáez, M. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318307 · Cited by 15
Therapeutic potential of natural product signal transduction agents
Koehn, F. E. (2006) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2006.09.006 · Cited by 14
Interfering with Protein-Protein Contact: Molecular Interaction Maps and Peptide Modulators
Nieddu, E., & Pasa, S. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607779318271 · Cited by 13
Mitchell, J. M., & Shaw, J. T. (2006) · Angewandte Chemie · doi:10.1002/ange.200503341 · Cited by 13
Ng, P. Y., Tang, Y., Knosp, W. M., Stadler, H. S., & Shaw, J. T. (2007) · Angewandte Chemie · doi:10.1002/ange.200700762 · Cited by 13
Lüscher, B., & Larsson, L. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401121 · Cited by 12
How does taxol stabilise microtubules?
Arnal, I., & Wade, R. H. (1995) · Biology of the Cell · doi:10.1016/0248-4900(96)89446-9 · Cited by 6
Lavery, D. N. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-575-0_10 · Cited by 3
Cited by
Multifaceted Roles of Disulfide Bonds. Peptides as Therapeutics
Góngora-Benítez, M., Tulla-Puche, J., & Albericio, F. (2014) · Chemical Reviews · doi:10.1021/cr400031z · Cited by 655
Modulators of Protein–Protein Interactions
Milroy, L.-G., Grossmann, T. N., Hennig, S., Brunsveld, L., & Ottmann, C. (2014) · Chemical Reviews · doi:10.1021/cr400698c · Cited by 497
Diversity-oriented synthesis: producing chemical tools for dissecting biology
O' Connor, C. J., Beckmann, H. S. G., & Spring, D. R. (2012) · Chemical Society Reviews · doi:10.1039/c2cs35023h · Cited by 434
Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain
Akçay, G., Belmonte, M. A., Aquila, B., Chuaqui, C., Hird, A. W., Lamb, M. L., Rawlins, P. B., Su, N., Tentarelli, S., Grimster, N. P., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2174 · Cited by 207
State-of-the-art strategies for targeting protein–protein interactions by small-molecule inhibitors
Sheng, C., Dong, G., Miao, Z., Zhang, W., & Wang, W. (2015) · Chemical Society Reviews · doi:10.1039/c5cs00252d · Cited by 165
Metadata
- Authors
- Zinzalla, G., & Thurston, D. E.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2009-04
- Volume
- 1
- Issue
- 1
- Pages
- 65-93
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2106060578
- Cited by
- 260
- References
- 210
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.